Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Diabetic Ulcers Treatment Market

Diabetic Ulcers Treatment Market Size

  • Report ID: GMI6078
  • Published Date: Jun 2023
  • Report Format: PDF

Diabetic Ulcers Treatment Market Size

Diabetic Ulcers Treatment Market was worth USD 9.3 billion in 2022 and is projected to grow at over 5.8% CAGR from 2023 to 2032 owing to the rising global incidence of diabetes.

 

Additionally, as the world's population continues to age, there is a higher likelihood of individuals developing chronic diseases such as diabetes, thereby fostering the industry growth. Moreover, increasing healthcare expenditure and several government initiatives, particularly in developing countries and a greater willingness to spend on advanced wound care treatment further contributes to overall business development.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of diabetic ulcers treatment reached USD 9.3 billion in 2022 and will grow at over CAGR 5.8% CAGR from 2023 to 2032 attributed to the rise in the diabetic population continues.

The foot ulcer segment dominated the diabetic ulcers treatment market in 2022 with a industry share of 88.8%, owing to high incidence of diabetic foot ulcers amongst diabetic patients.

North America diabetic ulcers treatment industry accounted for over 38.3% revenue share in 2022 and will continue to grow over 2023-2032, due to rising diabetes rate in the region due to factors such as sedentary lifestyles, unhealthy eating habits, and an aging population.

B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis Holdings Inc., Derma Sciences Inc., Integra LifeSciences, Hill Rom Holdings Inc., M

Diabetic Ulcers Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 439
  • Countries covered: 20
  • Pages: 225
 Download Free Sample